Blockchain Registration Transaction Record

Aclarion CEO to Showcase AI-Powered Back Pain Tech at LSI USA 2026

Aclarion CEO Brent Ness attends LSI USA 2026 to promote Nociscan, an AI-driven platform using biomarkers to diagnose chronic low back pain precisely.

This news matters because chronic low back pain is a debilitating condition affecting over 500 million people globally, often leading to misdiagnosis, ineffective treatments, and reduced quality of life. Aclarion's Nociscan technology addresses this by providing objective, biomarker-based insights that help physicians accurately identify painful discs, potentially reducing unnecessary surgeries and improving patient outcomes. By participating in LSI USA 2026, Aclarion is positioning itself to secure partnerships and funding that could accelerate the adoption of this innovative tool, making it more accessible to healthcare providers and patients. This advancement represents a shift toward personalized, data-driven medicine, offering hope for more effective management of a widespread and costly health issue.